Le‐Qun Li

1.2k citations
39 papers · 770 indexed · h-index 16
Topics
Liver Disease Diagnosis and Treatment (21 papers)Hepatocellular Carcinoma Treatment and Prognosis (18 papers)Hepatitis B Virus Studies (11 papers)

In The Last Decade

Le‐Qun Li

37 papers receiving 761 citations

Peers

Le‐Qun Li
Comparison fields: 5 of 90
  • Epidemiology 313
  • Hepatology 310
  • Oncology 173
  • Surgery 150
  • Molecular Biology 129
Replace Mei Guan with:
Mei Guan China
Xu Zhu China
Yu-Chao Wang Taiwan
Shaoming Chen China
Sha Lin China
Lu Ao China
Zhimin Wei China
Barnabás Wichmann Hungary
Guangbing Li China
Elaine Bolton Australia
Le‐Qun Li relative to Mei Guan China Mei Guan's profile →
Citations per field
00.5×8.7×
Mei Guan · 1×
Citations per year

Countries citing papers authored by Le‐Qun Li

Since Specialization
Citations

This map shows the geographic impact of Le‐Qun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le‐Qun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le‐Qun Li more than expected).

Fields of papers citing papers by Le‐Qun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le‐Qun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le‐Qun Li. The network helps show where Le‐Qun Li may publish in the future.

Co-authorship network of co-authors of Le‐Qun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Le‐Qun Li. A scholar is included among the top collaborators of Le‐Qun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Le‐Qun Li. Le‐Qun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 10
3 5
4 42
5 9
6 18
7 1
8 13
9 20
10 11
11 46
12
Influence of preoperative antiviral therapy on HBV reactivation and liver function after liver resection in HBV-DNA-negative hepatocellular carcinoma patients
1
13 15
14 10
15 19
16 3
17 43
18 35
19
Postoperative adjuvant adoptive immunotherapy for hepatocellular carcinoma:A Meta-analysis
1
20 1

About Le‐Qun Li

Le‐Qun Li is a scholar working on Hepatology, Epidemiology and Oncology, having authored 39 papers that have together received 770 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (18 papers) and Hepatitis B Virus Studies (11 papers). The work is most often cited by research in Hepatology (310 citations), Epidemiology (313 citations) and General Agricultural and Biological Sciences (65 citations). Le‐Qun Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Bang‐De Xiang, Yuheng Li, Jiazhou Ye, Yue Wang, Rongyun Mai, Feixiang Wu, Tao Bai, Tao Peng, Lu‐Nan Qi and Guobin Wu. Their work appears in journals such as PLoS ONE, Scientific Reports and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026